NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus

BACKGROUND: NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) improves the discriminatory ability of risk‐prediction models in type 2 diabetes mellitus (T2DM) but is not yet used in clinical practice. We assessed the discriminatory strength of NT‐proBNP by itself for death and cardiovascular eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Malachias, Marcus V. B., Jhund, Pardeep S., Claggett, Brian L., Wijkman, Magnus O., Bentley‐Lewis, Rhonda, Chaturvedi, Nishi, Desai, Akshay S., Haffner, Steven M., Parving, Hans‐Henrik, Prescott, Margaret F., Solomon, Scott D., De Zeeuw, Dick, McMurray, John J. V., Pfeffer, Marc A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792415/
https://www.ncbi.nlm.nih.gov/pubmed/32964800
http://dx.doi.org/10.1161/JAHA.120.017462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792415/
https://www.ncbi.nlm.nih.gov/pubmed/32964800
http://dx.doi.org/10.1161/JAHA.120.017462

Ejemplares similares